Nuzhna: New therapeutic modalities face a "better than the Beatles" bottleneck
Lada Nuzhna · The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation · Nov 14, 2025 · at 31:56
Lada Nuzhna, biotech investor, discusses why novel platforms like gene editors face commercial resistance when competing against existing standard therapies.
0:00 / 0:06exact quote · 6.7s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“So I think many new modalities will be bottlenecked by the Beatles, better than the Beatles problem.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Lada Nuzhna
Nuzhna: China leads global development in in vivo CAR-T and gene editing
“They are now leading in, in VivoC RTs, they are leading in gene editing and gene therapy, and partially due to this ability to do those investigator-initiated trials.”
Nuzhna: AI will solve open biology questions before predicting drug efficacy
“Many big bio problems and open questions will be solved with AI way before we can predict efficacy for drugs.”
Nuzhna: AI virtual cell models are near realization with existing data
“Virtual cells is actually not that far out. I think we have all the necessary data to generate something like that.”
Nuzhna: US multi-payer insurance system disincentivizes early preventive healthcare
“The payer that pays the most for diseases of aged population is Medicare which kicks in after 65. Before then we have a multi-payer system where patients Tend to rotate their insurance every few years. And so there's really not much incentive for someone to co…”
Nuzhna: Medicine will treat aging before understanding its underlying mechanisms
“I think we would be able to treat aging before we understand how to measure it or what it is or why it happens.”
Nuzhna: Modern medical stack can eliminate heart attacks for current generation
“And it does seem like we kind of hit a point where actually like our generation shouldn't die of heart attacks. It seems like we have everything to prevent high cholesterol in people from, like you can take antibodies sRNAs, small molecules, sun gene editors. …”